BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23087360)

  • 41. The APOA5-1131 T>C variant enhances the association between RBP4 and hypertriglyceridemia in diabetes.
    Cabré A; Lázaro I; Girona J; Manzanares JM; Marimón F; Plana N; Guardiola M; Heras M; Masana L
    Nutr Metab Cardiovasc Dis; 2010 May; 20(4):243-8. PubMed ID: 19765959
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association of serum retinol binding protein 4 with atherogenic dyslipidemia in morbid obese patients.
    Rocha M; Bañuls C; Bellod L; Rovira-Llopis S; Morillas C; Solá E; Víctor VM; Hernández-Mijares A
    PLoS One; 2013; 8(11):e78670. PubMed ID: 24223837
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased VLDL-Apo B 100 Fractional Synthesis Rate Despite Hypertriglyceridemia in Subjects With Type 2 Diabetes and Nephropathy.
    Tessari P; Kiwanuka E; Barazzoni R; Toffolo GM; Vettore M; Cortella I; Manesso E; Pasqualetto G; Puricelli L; Gabelli C; Zanetti M
    J Clin Endocrinol Metab; 2015 Nov; 100(11):4098-105. PubMed ID: 26291068
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of retinol binding protein 4 and transthyretin with triglyceride levels and insulin resistance in rural thais with high type 2 diabetes risk.
    Kwanbunjan K; Panprathip P; Phosat C; Chumpathat N; Wechjakwen N; Puduang S; Auyyuenyong R; Henkel I; Schweigert FJ
    BMC Endocr Disord; 2018 May; 18(1):26. PubMed ID: 29747616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of a six-month exercise program on very low-density lipoprotein apolipoprotein B secretion in type 2 diabetes.
    Alam S; Stolinski M; Pentecost C; Boroujerdi MA; Jones RH; Sonksen PH; Umpleby AM
    J Clin Endocrinol Metab; 2004 Feb; 89(2):688-94. PubMed ID: 14764782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes.
    Gavi S; Stuart LM; Kelly P; Melendez MM; Mynarcik DC; Gelato MC; McNurlan MA
    J Clin Endocrinol Metab; 2007 May; 92(5):1886-90. PubMed ID: 17299074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The relationship between retinol-binding protein 4 and apolipoprotein B-containing lipoproteins is attenuated in patients with very high serum triglycerides: A pilot study.
    Christou GA; Tellis CC; Elisaf MS; Tselepis AD; Kiortsis DN
    Hormones (Athens); 2016; 15(1):99-105. PubMed ID: 27086684
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retinol-binding protein 4 in rheumatoid arthritis-related insulin resistance and β-cell function.
    Ferraz-Amaro I; González-Gay MA; Diaz-González F
    J Rheumatol; 2014 Apr; 41(4):658-65. PubMed ID: 24532832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The association of retinol-binding protein 4 with metabolic syndrome and obesity in adolescents: the effects of gender and sex hormones.
    Lin CJ; Chu NF; Hung YJ; Chang JB; He CT; Hsiao FC; Hsieh CH
    Clin Pediatr (Phila); 2013 Jan; 52(1):16-23. PubMed ID: 22967812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Elevated retinol binding protein 4 induces apolipoprotein B production and associates with hypertriglyceridemia.
    Liu Y; Chen H; Wang J; Zhou W; Sun R; Xia M
    J Clin Endocrinol Metab; 2015 May; 100(5):E720-8. PubMed ID: 25781360
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients.
    Kelly KR; Kashyap SR; O'Leary VB; Major J; Schauer PR; Kirwan JP
    Obesity (Silver Spring); 2010 Apr; 18(4):663-6. PubMed ID: 19816414
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.
    Graham TE; Yang Q; Blüher M; Hammarstedt A; Ciaraldi TP; Henry RR; Wason CJ; Oberbach A; Jansson PA; Smith U; Kahn BB
    N Engl J Med; 2006 Jun; 354(24):2552-63. PubMed ID: 16775236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Serum retinol binding protein 4 and bone metabolism in patients with type 2 diabetes].
    Ye A; Zhang H; Peng Y; Liao E
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 37(2):197-202. PubMed ID: 22561439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Omega 3 Improves Both apoB100-containing Lipoprotein Turnover and their Sphingolipid Profile in Hypertriglyceridemia.
    Ferchaud-Roucher V; Zair Y; Aguesse A; Krempf M; Ouguerram K
    J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32805740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum retinol binding protein 4 is associated with visceral fat in human with nonalcoholic fatty liver disease without known diabetes: a cross-sectional study.
    Chang X; Yan H; Bian H; Xia M; Zhang L; Gao J; Gao X
    Lipids Health Dis; 2015 Apr; 14():28. PubMed ID: 25890223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Mediterranean diet with and without weight loss on apolipoprotein B100 metabolism in men with metabolic syndrome.
    Richard C; Couture P; Ooi EM; Tremblay AJ; Desroches S; Charest A; Lichtenstein AH; Lamarche B
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):433-8. PubMed ID: 24265415
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Retinol-binding protein 4 as a novel risk factor for cardiovascular disease in patients with coronary artery disease and hyperinsulinemia.
    Li F; Xia K; Li C; Yang T
    Am J Med Sci; 2014 Dec; 348(6):474-9. PubMed ID: 25233041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Retinol-binding protein 4 is associated with components of the metabolic syndrome, but not with insulin resistance, in men with type 2 diabetes or coronary artery disease.
    von Eynatten M; Lepper PM; Liu D; Lang K; Baumann M; Nawroth PP; Bierhaus A; Dugi KA; Heemann U; Allolio B; Humpert PM
    Diabetologia; 2007 Sep; 50(9):1930-1937. PubMed ID: 17639305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of exercise training on circulating retinol-binding protein 4 and cardiovascular disease risk factors in obese men.
    Numao S; Sasai H; Nomata Y; Matsuo T; Eto M; Tsujimoto T; Tanaka K
    Obes Facts; 2012; 5(6):845-55. PubMed ID: 23258073
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The degradation of apolipoprotein B100: multiple opportunities to regulate VLDL triglyceride production by different proteolytic pathways.
    Fisher EA
    Biochim Biophys Acta; 2012 May; 1821(5):778-81. PubMed ID: 22342675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.